Skip to main content

Stryker Value Stock - Dividend - Research Selection

Stryker

ISIN: US8636671013 , WKN: 864952

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products that include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. It also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned sales subsidiaries and branches, as well as third-party dealers and distributors in approximately 85 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Does Stryker’s (SYK) New Humerus Nailing System Clarify Its Long-Term Medtech Edge?

2026-02-24
In February 2026, Stryker launched the T2 Alpha Humerus Nailing System, a SOMA-informed humeral fracture solution designed to streamline procedures, enhance fixation stability, and integrate with its existing nailing platform to support hospital workflow efficiencies. The system’s guided targeting, active intraoperative compression, and multiplanar fixation aim to broaden treatment options for complex humeral fractures while promoting consistent, high-quality care across Stryker’s trauma...

Stryker Corporation (SYK) Gains Strength From Procedure Volumes and Capital Equipment Backlog

2026-02-23
Stryker Corporation (NYSE:SYK) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 2, the price target on Stryker Corporation (NYSE:SYK) was raised from $462 to $469 by Barclays. The firm reaffirmed its Overweight rating on the stock that yields a revised upside potential of more than 23%. […]

Walmart downgraded, Etsy upgraded: Wall Street's top analyst calls

2026-02-20
Walmart downgraded, Etsy upgraded: Wall Street's top analyst calls

AI-Driven Innovation Accelerates Tempus AI's Expansion Across MedTech

2026-02-20
TEM rolls out new AI tools across oncology, cardiology and mental health, accelerating its push to reshape MedTech innovation.

High Intensity Focused Ultrasound (HIFU) Market Competitive Landscape Report 2025: Recent Developments, Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts to 2033

2026-02-20
The High Intensity Focused Ultrasound (HIFU) market is poised for impressive growth, projected to reach US$ 242.58 Million by 2033 from US$ 134.01 Million in 2025, with a CAGR of 7.70%. Driven by growing demand for non-invasive treatment across oncology, urology, and cosmetic sectors, HIFU's precision in targeting tissues offers minimal damage and faster recovery. Innovations in image-guided and robotic systems bolster precision, while rising cancer incidence and preference for minimally invasiv

Life Science Precision Parts Research Report 2025: A $13.92 Billion Market by 2030 Featuring Key Players - Gemsons, Arc, Precision Resource, Thermo Fisher Scientific, Stryker, Linamar, TS Prototypes

2026-02-17
The Life Science Precision Parts Market is set to expand from USD 9.50 billion in 2024 to USD 13.92 billion by 2030, at a CAGR of 6.57%. Key players like Knowles Corporation, Precipart, and Accumold are advancing in micromanufacturing for medtech applications. Automation is significantly transforming the sector, highlighting the need for precision components in genomics and molecular diagnostics. North America leads the market, driven by strong healthcare infrastructure and compliance standards.

Clinical Communication & Collaboration Market by Platform, Component, Application, End User - Global Forecast to 2030 with Cisco Systems, Oracle, Baxter, Avaya, Spok Leading

2026-02-16
The global clinical communication and collaboration market is set to reach $5.31 billion by 2030, growing at a CAGR of 13.02%. This growth is fueled by the increasing need for real-time communication, care coordination, and workflow efficiency in healthcare. A surge in mobile, cloud-based platform adoption and a shift to integrated, secure communication drives this expansion. Case studies from Stryker, Imprivata, and Ascom reveal notable improvements in staff responsiveness, patient admission ti

J&J's MedTech Shows Strong Growth in 2025: Will 2026 be Better?

2026-02-16
JNJ's MedTech unit grows in 2025 on cardiovascular strength; with new launches, can 2026 bring faster growth?

Assessing Stryker (SYK) Valuation After Recent Share Performance And Cash Flow Expectations

2026-02-14
Why Stryker (SYK) is back on investors’ radar Stryker (SYK) has been drawing fresh investor attention after recent share price moves and updated return figures, prompting a closer look at how its current performance might fit into a broader portfolio. See our latest analysis for Stryker. Recent trading has been steady rather than dramatic, with a 7 day share price return of 2.17% and a year to date share price return of 5.13%. However, the 1 year total shareholder return of a 4.09% decline...

BSX Posts Q4 Earnings: Should You Buy, Sell or Hold the Stock?

2026-02-13
Boston Scientific tops Q4 estimates, but shares sink on supply woes and EP losses. Can strong growth drivers fuel a 2026 rebound?